The low expression of mRNA encoding PDP2 in CMS patients but not in controls living at the same altitude in the Andes and Himalayas suggests that CMS represents a derangement in molecular homeostasis, with inadequate up-regulation of hypoxia-related genes to maintain a steady state in the face of hypoxic stress. This evidence concerns the gene PDP2 and congenital myasthenic syndrome.